The SoluMatrix platform is a drug reformulation and delivery technology especially for poorly water-soluble compounds which is simple, scalable and cost effective to:

	improve bioavailability;
	open up novel delivery methods such as direct particle injection.

Particle size reduction increases surface area and in-vivo dissolution rate.

The drug product that is produced using the Platform comprises very small particles of drug (typically less than 2000 nanometers (nm) in diameter), which are produced by milling the drug substance together with conventional pharmaceutical excipients (matrix materials) using a proprietary, dry-milling technique. The particles of the drug are stabilized against agglomeration by the unique matrix, which can also provide other beneficial pharmakokinetic properties.

The resulting dry powders can be processed into finished dosage forms for all routes of administration.